ArticleVeterinary research communications2026
Probiotic characterization of Ligilactobacillus murinus ZQL11 isolated from healthy dog feces.
Article in Veterinary research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From conventional probiotics to precision nutrition: host-specific probiotics in canine and feline functional foods.Frontiers in veterinary science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Currently, canine-derived probiotics, especially those specifically developed for dogs, remain relatively scarce. Our study aimed to isolate bacterial strains from the feces of healthy dogs and to screen for those with excellent probiotic properties. A total of 12 strains were isolated and identified through morphological observation and 16 S rRNA gene sequencing. These strains were systematically evaluated for key probiotic characteristics, including tolerance to simulated gastrointestinal conditions, antimicrobial activity, adhesion-related properties, and overall safety. Among them, Ligilactobacillus murinus ZQL11 (ZQL11) demonstrated the most promising probiotic profile. This strain exhibited strong acid tolerance, with a survival rate of 75.23% after 3 h at pH 2.0, and notable bile salt resistance, maintaining 78.86% survival after 4 h in 0.3% bile salts. Antibacterial assays revealed significant inhibitory effects against Escherichia coli, Salmonella enterica, and Staphylococcus aureus. Adhesion-related evaluations showed high cell surface hydrophobicity together with strong auto-aggregation and co-aggregation abilities. In vivo safety assessment in mice showed that ZQL11 did not induce detectable toxicity or adverse effects; no significant differences were observed in routine blood parameters between the ZQL11-treated and control groups, and no obvious histopathological lesions were found in the major organs. In summary, ZQL11 exhibited favorable tolerance, adhesion-related properties, safety, and antibacterial activity, suggesting its potential for further application in animal microecological preparation.
Indexed as
Identifiers
42274900What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.